Search clinical trials for: PegIFN/RBV

Total 1386 results

Epicentre
Children's Hospital Medical Center, Cincinnati; Medecins Sans Frontieres, Netherlands and other collaborators

Completed

Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger (ROSE)

Severe Rotavirus Gastroenteritis

Niger
New York State Psychiatric Institute
University of California, Los Angeles; COMPASS Pathways

Completed

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

Body Dysmorphic Disorders

United States
Soroka University Medical Center

Completed

Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease (HBV VIP)

Inflammatory Bowel Disease

Israel
National Institute of Allergy and Infectious Diseases...

Completed

Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Indivior Inc.

Completed

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Opioid Use Disorder

United States
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital

Completed

Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy (BOLERO-CB)

Hepatitis C, Chronic

Taiwan
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection (SWIFT-C)

Hepatitis | HIV-1 Infection

United States
Gilead Sciences

Completed

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Chronic Hepatitis C Infection

New Zealand
Biogen

Completed

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function (TRUST)

Relapsing-Remitting Multiple Sclerosis
The University of Hong Kong

Recruiting

To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2

Covid19

Hong Kong
Regeneron Pharmaceuticals

Recruiting

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

Advanced NSCLC

United States
Prof. Tobias Feuchtinger
European Commission; Simbec-Orion Group Ltd, Merthyr Tydfil, UK; Miltenyi Biotec... and other collaborators

Recruiting

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections (TRACE)

CMV Infection | EBV Infection | Stem Cell Transplant Complications | AdV Infection

Belgium, Spain, France, Germany, Italy, Netherlands
Jesús Moreno Fernández
Castilla-La Mancha Health Service; University of Castilla-La Mancha

Completed

Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-1). (AVADI-1)

Type 1 Diabetes Mellitus

Spain
National Taiwan University Hospital
AbbVie

Completed

PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis (PIVOTAL)

Hepatitis Viruses

Taiwan
Bern University of Applied Sciences
Swiss Federal Institute of Technology

Completed

Innovative Training Program for Elderly in Need of Care

Poor Performance Status | Cognition - Other

Switzerland
Vaccitech (UK) Limited

Active, not recruiting

First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV

Hepatitis B

Korea, Republic of, Taiwan, United Kingdom
SK Bioscience Co., Ltd.
Coalition for Epidemic Preparedness Innovations

Completed

Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Kirby Institute
Janssen-Cilag Ltd.

Completed

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) (DARE-C)

Hepatitis C, Chronic

Australia
Debiopharm International SA

Completed

Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants

Hepatitis C

United States, Romania, Belgium, Germany, Hungary, Taiwan, Spain, Italy, Australia, France, Hong Kong, Thailand, Korea, Republic of, United Kingdom, Argentina, Russian Federation, Canada, Poland, Puerto Rico, Vietnam, Mexico
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Not yet recruiting

Napoleon Trial: Optimal Treatment for Recurrent Haemorrhoidal Disease

Hemorrhoids

Netherlands
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)

HIV Infections

Germany, Taiwan, France, United States, Canada, Belgium, Australia, Netherlands, Spain, United Kingdom, Italy, Argentina, Russian Federation
Cairo University

Enrolling by invitation

Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus

Systemic | Lupus

Egypt
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Recovery Housing For Drug Dependent Pregnant Women (HOME)

Drug Addiction

United States
NYU Langone Health
National Center for Complementary and Integrative Health (NCCIH); Ananda Scientific

Recruiting

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Social Anxiety Disorder

United States
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

Chronic Hepatitis C Infection

China
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (CERTAIN-2)

Hepatitis C Virus | Chronic Hepatitis C Virus
Gilead Sciences

Completed

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Hepatitis C, Chronic

United States, Germany
Gilead Sciences

Completed

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

HCV Infection

United Kingdom, Germany, Ireland, United States, Belgium, Puerto Rico, Poland
Hellenic Institute for the Study of Sepsis

Completed

Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO (CRONUS)

Respiratory Tract Infections | Bacterial Infections | Viral Infection | Multi-antibiotic Resistance

Greece
MeMed Diagnostics Ltd.

Completed

Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)

Acute Infection

United States, Israel
CanXida
Citruslabs

Active, not recruiting

Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement

Candida Infection | Candida Albicans Infection | Candida Systemic

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

HIV Infections

Germany, Spain, United States, Canada, Taiwan, France, Italy, Argentina, United Kingdom, Russian Federation, Australia
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
Alnylam Pharmaceuticals

Terminated

A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B Infection

United Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
ERYtech Pharma

Terminated

L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL

Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma

United States
Find
University of Cape Town; Universidad Peruana Cayetano Heredia

Unknown

Performance Evaluation of TB Breath- and Cough-testing Platforms

Diagnoses Diseases | Pulmonary TB

South Africa
Shineway Pharmaceutical Co.,Ltd

Unknown

The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection

HBeAg Positive Chronic Hepatitis B
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Terminated

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease (ANGELA)

Hodgkin Disease | Non-Hodgkins Lymphoma

United States
Centre Hospitalier Universitaire, Amiens

Completed

Ultrasound Guided Percutaneous Tracheostomy

Tracheostomy Hemorrhage | Tracheostomy Complications | Other Tracheostomy Complications

France
University Health Network, Toronto

Recruiting

Palliative Thoracic ImmunoRT

Lung Cancer | Lung Cancer, Nonsmall Cell

Canada
Pamukkale University

Completed

The Effects Of Cervical Mobilization (CM)

Stroke | Ischemic Stroke | Chronic Stroke

Turkey
Cairo University

Unknown

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment

Egypt
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Accelerated Partial Breast Irradiation for Early Breast Cancer

Breast Cancer

Australia, New Zealand
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients

Hepatitis B

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

HIV Infection

United States, Australia, France, United Kingdom, Belgium, Germany, Spain, Argentina, Chile, Mexico, Portugal, Malaysia, Panama, South Africa, Canada, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Hungary, Denmar... and more
Novavax

Completed

RSV F Dose-Ranging Study in Women

Respiratory Syncytial Virus Infections

United States
Merck Sharp & Dohme LLC

Completed

Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) (PROVIDE)

Hepatitis C, Chronic
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Post Liver Transplant | Recurrent Chronic Hepatitis C Virus

United States, Spain, New Zealand, France, Germany
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV (DIMENSION)

Chronic Hepatitis C Infection

France, Germany, United States, Spain, Canada, Argentina, Mexico, Belgium, Italy, Russian Federation, United Kingdom, Poland
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Chronic Hepatitis C

New Zealand

Search clinical trials for: PegIFN/RBV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations